These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8384254)

  • 1. Acute changes in glucose uptake after treatment: the effects of carmustine (BCNU) on human glioblastoma multiforme.
    Rozental JM; Cohen JD; Mehta MP; Levine RL; Hanson JM; Nickles RJ
    J Neurooncol; 1993 Jan; 15(1):57-66. PubMed ID: 8384254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance.
    Rozental JM; Levine RL; Nickles RJ
    J Neurooncol; 1991 Feb; 10(1):75-83. PubMed ID: 2022974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
    Vlassenko AG; Thiessen B; Beattie BJ; Malkin MG; Blasberg RG
    J Neurooncol; 2000; 46(3):249-59. PubMed ID: 10902856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose uptake by gliomas after treatment. A positron emission tomographic study.
    Rozental JM; Levine RL; Nickles RJ; Dobkin JA
    Arch Neurol; 1989 Dec; 46(12):1302-7. PubMed ID: 2556096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of survival in glioma patients by means of positron emission tomography.
    Patronas NJ; Di Chiro G; Kufta C; Bairamian D; Kornblith PL; Simon R; Larson SM
    J Neurosurg; 1985 Jun; 62(6):816-22. PubMed ID: 2987440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effect of carmustine on glucose metabolism in brain and glioblastoma.
    De Witte O; Hildebrand J; Luxen A; Goldman S
    Cancer; 1994 Nov; 74(10):2836-42. PubMed ID: 7954245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors.
    Schifter T; Hoffman JM; Hanson MW; Boyko OB; Beam C; Paine S; Schold SC; Burger PC; Coleman RE
    J Comput Assist Tomogr; 1993; 17(4):509-61. PubMed ID: 8392523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up.
    Della Puppa A; Lombardi G; Rossetto M; Rustemi O; Berti F; Cecchin D; Gardiman MP; Rolma G; Persano L; Zagonel V; Scienza R
    J Neurooncol; 2017 Jan; 131(2):331-340. PubMed ID: 27757721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
    Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
    Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced detection of brain tumors by [18F]fluorodeoxyglucose PET with glucose loading.
    Ishizu K; Sadato N; Yonekura Y; Nishizawa S; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Tanaka F; Miyatake S
    J Comput Assist Tomogr; 1994; 18(1):12-5. PubMed ID: 8282860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
    Gutenberg A; Bock HC; Brück W; Doerner L; Mehdorn HM; Roggendorf W; Westphal M; Felsberg J; Reifenberger G; Giese A
    Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
    Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
    J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme.
    Bashir R; Hochberg FH; Linggood RM; Hottleman K
    J Neurosurg; 1988 Jun; 68(6):917-9. PubMed ID: 2836567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
    Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
    Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.
    Roelcke U; Blasberg RG; von Ammon K; Hofer S; Vontobel P; Maguire RP; Radü EW; Herrmann R; Leenders KL
    J Nucl Med; 1998 May; 39(5):879-84. PubMed ID: 9591593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of clonogenic human brain tumour cells: preliminary results of tumour sensitivity testing with BCNU.
    Rosenblum ML; Dougherty DA; Deen DF; Hoshino T; Wilson CB
    Br J Cancer Suppl; 1980 Apr; 4():181-5. PubMed ID: 6252931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma.
    Hölzer T; Herholz K; Jeske J; Heiss WD
    J Comput Assist Tomogr; 1993; 17(5):681-7. PubMed ID: 8370819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
    Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion.
    Stummer W; van den Bent MJ; Westphal M
    Acta Neurochir (Wien); 2011 Jun; 153(6):1211-8. PubMed ID: 21479583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.